On Invalid Date, Onconova Therapeutics (NASDAQ: ONTX) reported Q3 2023 earnings per share (EPS) of -$0.23, up 11.54% year over year. Total Onconova Therapeutics earnings for the quarter were -$4.74 million. In the same quarter last year, Onconova Therapeutics's earnings per share (EPS) was -$0.26.
As of Q1 2024, Onconova Therapeutics's earnings has grown year over year. Onconova Therapeutics's earnings in the past year totalled -$20.18 million.
What is ONTX's earnings date?
Onconova Therapeutics's earnings date is Invalid Date. Add ONTX to your watchlist to be reminded of ONTX's next earnings announcement.
What was ONTX's revenue last quarter?
On Invalid Date, Onconova Therapeutics (NASDAQ: ONTX) reported Q3 2023 revenue of $57.00 thousand up 0% year over year. In the same quarter last year, Onconova Therapeutics's revenue was $57.00 thousand.
What was ONTX's revenue growth in the past year?
As of Q1 2024, Onconova Therapeutics's revenue has grown 0% year over year. This is 169.3 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Onconova Therapeutics's revenue in the past year totalled $226.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.